CHEMOCENTRYX

chemocentryx-logo

ChemoCentryxis a biopharmaceutical company developing new medications targeted at inflammatory and autoimmune diseases and cancer. ChemoCentryx focuses on the discovery, development, and commercialization of orally-administered small molecule therapeutics that target chemokine receptors and related chemo-attractant receptors. The company's small molecule product candidates are designed to target a specific chemokine or chemo-attractant receptor, thereby blocking the inappropriate immune system cascade underlying a given disease.

#SimilarOrganizations #People #Financial #Event #Website #More

CHEMOCENTRYX

Social Links:

Industry:
Biotechnology Health Care Medical Device

Founded:
1997-01-01

Address:
San Carlos, California, United States

Country:
United States

Website Url:
http://www.chemocentryx.com

Total Employee:
101+

Status:
Active

Contact:
+1.650.210.2900

Email Addresses:
[email protected]

Total Funding:
634.34 M USD

Technology used in webpage:
SPF SSL By Default Mobile Non Scaleable Content Amazon IPv6 Google Maps ReCAPTCHA Microsoft Azure DNS Google Maps API Apple Mobile Web App Capable


Similar Organizations

adamas-pharmaceuticals-logo

Adamas Pharmaceuticals

Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.

apellis-pharmaceuticals-logo

Apellis Pharmaceuticals

Apellis Pharmaceuticals focusesย on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.

gelesis-logo

Gelesis

Gelesis is a biotechnology company developing first-in-class therapeutics to safely treat obese, overweight, and diabetic patients.

intarcia-therapeutics-logo

Intarcia Therapeutics

Intarcia Therapeutics develops therapies for diseases that require long-term chronic treatment.

myomo-logo

Myomo

Myomo develops devices with myoelectric prosthetic technology to restore the mobility of individuals with muscle weakness.


Current Advisors List

geoffrey-parker_image

Geoffrey Parker Board of Directors @ ChemoCentryx
Board_member

Current Employees Featured

rita-i-jain_image

Rita I. Jain
Rita I. Jain EVP & Chief Medical Officer @ ChemoCentryx
EVP & Chief Medical Officer
2021-10-01

sangita-ghosh_image

Sangita Ghosh
Sangita Ghosh Senior Vice President, Technical Operations @ ChemoCentryx
Senior Vice President, Technical Operations

not_available_image

Markus J. Cappel
Markus J. Cappel Chief Business Officer and Treasurer @ ChemoCentryx
Chief Business Officer and Treasurer

dalia-rayes_image

Dalia Rayes
Dalia Rayes Senior Vice President, Head of Commercial @ ChemoCentryx
Senior Vice President, Head of Commercial

not_available_image

Susan M. Kanaya
Susan M. Kanaya Senior Vice President, Finance, Chief Financial Officer and Secretary @ ChemoCentryx
Senior Vice President, Finance, Chief Financial Officer and Secretary

gopi-kurse_image

Gopi Kurse
Gopi Kurse Vice President, Quality @ ChemoCentryx
Vice President, Quality
2020-06-01

kari-leetch_image

Kari Leetch
Kari Leetch Senior Vice President, Human Resources @ ChemoCentryx
Senior Vice President, Human Resources

not_available_image

Thomas J. Schall
Thomas J. Schall Founder, President, Chief Executive Officer and Chairman of the Board @ ChemoCentryx
Founder, President, Chief Executive Officer and Chairman of the Board

not_available_image

Catherine L. Kelleher
Catherine L. Kelleher Senior Vice President, Clinical Development @ ChemoCentryx
Senior Vice President, Clinical Development
2019-01-01

not_available_image

Jan L Hillson
Jan L Hillson Senior Vice President, Drug Development @ ChemoCentryx
Senior Vice President, Drug Development
2016-01-01

Founder


not_available_image

Thomas J. Schall

Stock Details


Company's stock symbol is NASDAQ:CCXI

Investors List

herculescapital_image

Hercules Capital

Hercules Capital investment in Post-IPO Debt - ChemoCentryx

alta-partners_image

Alta Partners

Alta Partners investment in Series E - ChemoCentryx

hbm-healthcare-investments-ag_image

HBM Healthcare Investments AG

HBM Healthcare Investments AG investment in Series E - ChemoCentryx

glaxo-group_image

Glaxo Group

Glaxo Group investment in Series E - ChemoCentryx

healthcap_image

HealthCap

HealthCap investment in Series E - ChemoCentryx

glaxo-group_image

Glaxo Group

Glaxo Group investment in Series D - ChemoCentryx

orbimed-advisors_image

OrbiMed

OrbiMed investment in Series D - ChemoCentryx

gimv_image

Gimv

Gimv investment in Series D - ChemoCentryx

hbm-healthcare-investments-ag_image

HBM Healthcare Investments AG

HBM Healthcare Investments AG investment in Series D - ChemoCentryx

alta-partners_image

Alta Partners

Alta Partners investment in Series D - ChemoCentryx

Official Site Inspections

http://www.chemocentryx.com Semrush global rank: 4.64 M Semrush visits lastest month: 2.14 K

  • Host name: cloudproxy10158.sucuri.net
  • IP address: 192.124.249.158
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "ChemoCentryx"

ChemoCentryx, Inc. Company Profile - Dun & Bradstreet

Company Description: ChemoCentryx is an integrated United States biopharmaceutical company commercializing and developing new medications for inflammatory and autoimmune diseases โ€ฆSee details»

ChemoCentryx, Inc. Company Profile - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for ChemoCentryx, Inc. of Thousand Oaks, CA. Get the latest business insights from Dun & โ€ฆSee details»

ChemoCentryx Company Profile - Office Locations, Competitors

Mar 3, 2022 ChemoCentryx is a biopharmaceutical company commercializing and developing medications for inflammatory and autoimmune diseases and cancer. It focuses on orphan and โ€ฆSee details»

Chemocentryx Company Profile 2025: Valuation, โ€ฆ

When was Chemocentryx founded? Chemocentryx was founded in 1997. Where is Chemocentryx headquartered? Chemocentryx is headquartered in Mountain View, CA. What is the size of Chemocentryx? Chemocentryx has 178 total โ€ฆSee details»

ChemoCentryx, Inc. - Drug pipelines, Patents, Clinical trials - Synapse

ChemoCentryx is a biopharmaceutical corporation that specializes in creating innovative medications for the treatment of inflammatory and autoimmune diseases, as well as cancer. โ€ฆSee details»

ChemoCentryx - Products, Competitors, Financials, Employees ...

ChemoCentryx was founded in 1997. Where is ChemoCentryx's headquarters? ChemoCentryx's headquarters is located at 850 Maude Avenue, Mountain View. What is ChemoCentryx's latest โ€ฆSee details»

ChemoCentryx Inc Company Profile - GlobalData

ChemoCentryx Inc (ChemoCentryx) is a bio pharmaceutical company that discovers, develops and commercializes orally-administered therapeutics for the treatment of cancer, autoimmune โ€ฆSee details»

ChemoCentryx - Funding, Financials, Valuation & Investors

ChemoCentryx is a biopharmaceutical company that develops medications for inflammatory and autoimmune diseases and cancer. Search Crunchbase. Start Free Trial . ... How much funding โ€ฆSee details»

ChemoCentryx, Inc. - VentureRadar

ChemoCentryx is a biopharmaceutical company focused on discovering, developing and commercializing orally-administered therapeutics to treat autoimmune diseases, inflammatory โ€ฆSee details»

ChemoCentryx Notification - Amgen

ChemoCentryx Notification. Main Menu ; About. Overview Amgen History Mission and Values Leadership Amgen Foundation . Awards and Accolades ...See details»

ChemoCentryx CEO and Key Executive Team | Craft.co

ChemoCentryx's President, Chief Executive Officer and Chairman of the Board is Thomas J. Schall. Other executives include Susan M. Kanaya, Executive Vice President, Chief Financial โ€ฆSee details»

ChemoCentryx, Inc. | Scientist.com

ChemoCentryx is a biopharmaceutical company focused on discovering, developing and commercializing orally-administered therapeutics to treat autoimmune diseases, inflammatory โ€ฆSee details»

ChemoCentryx - Contacts, Employees, Board Members, Advisors

Organization. ChemoCentryx . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies ... including EVP & Chief Medical Officer Rita โ€ฆSee details»

ChemoCentryx, Inc. Locations - Contract Research Map

850 Maude Ave. Mountain View, CA 94043 ChemoCentryx is a biopharmaceutical company focused on discovering, developing and commercializing orally-administered therapeutics to โ€ฆSee details»

AMGEN SUCCESSFULLY COMPLETES ACQUISITION OF โ€ฆ

Oct 20, 2022 TAVNEOS ® (avacopan), a First-in-Class Medicine for Patients With Severe Active ANCA-Associated Vasculitis, Added to Inflammation Portfolio. THOUSAND OAKS, Calif., Oct. โ€ฆSee details»

AMGEN TO ACQUIRE CHEMOCENTRYX FOR $4 BILLION IN CASH

Aug 4, 2022 Acquisition Includes TAVNEOS ® (avacopan), a First-in-Class Medicine for Patients With Serious Autoimmune Disease . Tavneos Adds to Amgen 's Decades-Long Leadership in โ€ฆSee details»

Amgen to Acquire ChemoCentryx for $3.7B, Bolstering โ€ฆ

Aug 5, 2022 Last month, ChemoCentryx presented positive safety results from the first 13 patients enrolled across four dose cohorts: (30 mg, 60 mg, 120 mg, and 180 mg) as of April โ€ฆSee details»

Amgen bets on ChemoCentryx's rare disease drug in $3.7 billion deal

Aug 4, 2022 The company, which kept its full-year adjusted profit forecast unchanged at between $17 and $18 per share, would pay $52 in cash for each share of ChemoCentryx, a โ€ฆSee details»

ChemoCentryx - Tech Stack, Apps, Patents & Trademarks

Dec 29, 2024 ChemoCentryx uses 25 technology products and services including HTML5, Lightbox, and Microsoft Outlook, according to G2 Stack. ChemoCentryx is actively using 25 โ€ฆSee details»

FDA APPROVES LUMAKRAS® (SOTORASIB) IN COMBINATION โ€ฆ

5 hours ago Pivotal Study Demonstrated the Combination More Than Doubled Progression-Free Survival Compared to Investigated SOC. THOUSAND OAKS, Calif., Jan. 17, 2025 โ€ฆSee details»

linkstock.net © 2022. All rights reserved